AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Niagen Bioscience, Inc. Director's Dealing 2016

Jun 14, 2016

32418_dirs_2016-06-14_cd029881-aacb-4a88-b0c9-25321c31270f.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ChromaDex Corp. (CDXC)
CIK: 0001386570
Period of Report: 2016-06-06

Reporting Person: SMITHBURG WILLIAM D (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	640000	Direct